Crossref
Involvement of the lateral septal nucleus in rimegepant treatment of migraine
Journal of Biomedical Research · 2026 · 40 (6) · 1
DOI: 10.7555/jbr.40.20260389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Research, 2026. Verfasst von Chenyang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Fisheries and Life Science, Shanghai Ocean University, Shanghai 201306, China. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- College of Fisheries and Life Science, Shanghai Ocean University, Shanghai 201306, China.
- Department of Neurology, Shanghai Sixth People's Hospital, Shanghai 200233, China.
- Institute of Biomedical Research, Inner Mongolia University, Hohhot, Inner Mongoli 010021, China.
Zitieren
APA
Li, C., Guo, L., Yang, J., & Sun, H. (2026). Involvement of the lateral septal nucleus in rimegepant treatment of migraine. Journal of Biomedical Research, 40(6), 1. https://doi.org/10.7555/jbr.40.20260389
Vancouver
Li C, Guo L, Yang J, Sun H. Involvement of the lateral septal nucleus in rimegepant treatment of migraine. Journal of Biomedical Research. 2026;40(6):1. doi:10.7555/jbr.40.20260389
BibTeX
@article{Li2026,
author = {Li, Chenyang and Guo, Liqin and Yang, Jiajun and Sun, Hongbin},
title = {Involvement of the lateral septal nucleus in rimegepant treatment of migraine},
journal = {Journal of Biomedical Research},
year = {2026},
volume = {40},
number = {6},
pages = {1},
doi = {10.7555/jbr.40.20260389}
}
EUVIMED